BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26631987)

  • 1. The acute lymphoblastic leukemia of Down Syndrome - Genetics and pathogenesis.
    Izraeli S
    Eur J Med Genet; 2016 Mar; 59(3):158-61. PubMed ID: 26631987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
    Schwartzman O; Savino AM; Gombert M; Palmi C; Cario G; Schrappe M; Eckert C; von Stackelberg A; Huang JY; Hameiri-Grossman M; Avigad S; Te Kronnie G; Geron I; Birger Y; Rein A; Zarfati G; Fischer U; Mukamel Z; Stanulla M; Biondi A; Cazzaniga G; Vetere A; Wagner BK; Chen Z; Chen SJ; Tanay A; Borkhardt A; Izraeli S
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E4030-E4039. PubMed ID: 28461505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.
    Hertzberg L; Vendramini E; Ganmore I; Cazzaniga G; Schmitz M; Chalker J; Shiloh R; Iacobucci I; Shochat C; Zeligson S; Cario G; Stanulla M; Strehl S; Russell LJ; Harrison CJ; Bornhauser B; Yoda A; Rechavi G; Bercovich D; Borkhardt A; Kempski H; te Kronnie G; Bourquin JP; Domany E; Izraeli S
    Blood; 2010 Feb; 115(5):1006-17. PubMed ID: 19965641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
    Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
    Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Down syndrome and acute lymphoblastic leukemia].
    Okamoto Y
    Rinsho Ketsueki; 2021; 62(10):1465-1473. PubMed ID: 34732618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
    Lundin C; Hjorth L; Behrendtz M; Nordgren A; Palmqvist L; Andersen MK; Biloglav A; Forestier E; Paulsson K; Johansson B
    Genes Chromosomes Cancer; 2012 Feb; 51(2):196-206. PubMed ID: 22072402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
    Tigay JH
    J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
    Buitenkamp TD; Pieters R; Gallimore NE; van der Veer A; Meijerink JP; Beverloo HB; Zimmermann M; de Haas V; Richards SM; Vora AJ; Mitchell CD; Russell LJ; Schwab C; Harrison CJ; Moorman AV; van den Heuvel-Eibrink MM; den Boer ML; Zwaan CM
    Leukemia; 2012 Oct; 26(10):2204-11. PubMed ID: 22441210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of the surface expression of thymic stromal lymphopoietin receptor with the presence of CRLF2 gene rearrangements in children with B-lineage acute lymphoblastic leukemia.
    Demina I; Zerkalenkova E; Soldatkina O; Kazakova A; Semchenkova A; Goncharova M; Novichkova G; Maschan M; Karachunskiy A; Olshanskaya Y; Popov A
    Int J Lab Hematol; 2023 Jun; 45(3):337-343. PubMed ID: 36748719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.
    Lee P; Bhansali R; Izraeli S; Hijiya N; Crispino JD
    Leukemia; 2016 Sep; 30(9):1816-23. PubMed ID: 27285583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan.
    Hanada I; Terui K; Ikeda F; Toki T; Kanezaki R; Sato T; Kamio T; Kudo K; Sasaki S; Takahashi Y; Hayashi Y; Inukai T; Kojima S; Koike K; Kosaka Y; Kobayashi M; Imaizumi M; Mitsui T; Hori H; Hara J; Horibe K; Nagai J; Goto H; Ito E
    Genes Chromosomes Cancer; 2014 Nov; 53(11):902-10. PubMed ID: 25044358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
    Li Z; Chang TC; Junco JJ; Devidas M; Li Y; Yang W; Huang X; Hedges DJ; Cheng Z; Shago M; Carroll AJ; Heerema NA; Gastier-Foster J; Wood BL; Borowitz MJ; Sanclemente L; Raetz EA; Hunger SP; Feingold E; Rosser TC; Sherman SL; Loh ML; Mullighan CG; Yu J; Wu G; Lupo PJ; Rabin KR; Yang JJ
    Blood; 2023 Jul; 142(2):172-184. PubMed ID: 37001051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients.
    Page EC; Heatley SL; Yeung DT; Thomas PQ; White DL
    Cancer Lett; 2018 Sep; 432():69-74. PubMed ID: 29879498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equal frequency of TEL/AML1 rearrangements in children with acute lymphoblastic leukemia with and without Down syndrome.
    Steiner M; Attarbaschi A; König M; Nebral K; Gadner H; Haas OA; Mann G;
    Pediatr Hematol Oncol; 2005; 22(3):229-34. PubMed ID: 16020107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.
    Mullighan CG; Collins-Underwood JR; Phillips LA; Loudin MG; Liu W; Zhang J; Ma J; Coustan-Smith E; Harvey RC; Willman CL; Mikhail FM; Meyer J; Carroll AJ; Williams RT; Cheng J; Heerema NA; Basso G; Pession A; Pui CH; Raimondi SC; Hunger SP; Downing JR; Carroll WL; Rabin KR
    Nat Genet; 2009 Nov; 41(11):1243-6. PubMed ID: 19838194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspicions regarding the genetic inheritance of acute lymphoblastic leukemia in patients with down syndrome.
    Behluli E; Nuhii N; Liehr T; Temaj G
    J Mother Child; 2022 Mar; 26(1):104-110. PubMed ID: 35853737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia.
    Kearney L; Gonzalez De Castro D; Yeung J; Procter J; Horsley SW; Eguchi-Ishimae M; Bateman CM; Anderson K; Chaplin T; Young BD; Harrison CJ; Kempski H; So CW; Ford AM; Greaves M
    Blood; 2009 Jan; 113(3):646-8. PubMed ID: 18927438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute leukemias in children with Down syndrome.
    Seewald L; Taub JW; Maloney KW; McCabe ER
    Mol Genet Metab; 2012 Sep; 107(1-2):25-30. PubMed ID: 22867885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.